|
Volumn 44, Issue 2, 2014, Pages 195-197
|
Use of belimumab throughout pregnancy to treat active systemic lupus erythematosus-A case report
|
Author keywords
Belimumab; Lupus; Lupus nephritis; Pregnancy; Systemic lupus erythematosus
|
Indexed keywords
ANTINUCLEAR ANTIBODY;
AZATHIOPRINE;
BELIMUMAB;
DOUBLE STRANDED DNA;
ENOXAPARIN;
GRANULOCYTE ANTIBODY;
HYDROXYCHLOROQUINE;
LISINOPRIL;
LOW MOLECULAR WEIGHT HEPARIN;
MYCOPHENOLIC ACID;
PHOSPHOLIPID ANTIBODY;
PREDNISONE;
RITUXIMAB;
RO ANTIBODY;
THIOPURINE METHYLTRANSFERASE;
WARFARIN;
IMMUNOSUPPRESSIVE AGENT;
MONOCLONAL ANTIBODY;
ADULT;
ANGIONEUROTIC EDEMA;
ANTIPHOSPHOLIPID SYNDROME;
APGAR SCORE;
ARTHRALGIA;
ARTICLE;
BREAST FEEDING;
BREECH PRESENTATION;
CASE REPORT;
CAUCASIAN;
CESAREAN SECTION;
COMPLEMENT BLOOD LEVEL;
DEEP VEIN THROMBOSIS;
DISCOID LUPUS ERYTHEMATOSUS;
DRUG CONTRAINDICATION;
DRUG DOSE REDUCTION;
DRUG ERUPTION;
DRUG SUBSTITUTION;
DRUG WITHDRAWAL;
EBSTEIN ANOMALY;
ECHOCARDIOGRAPHY;
FAMILY HISTORY;
FEMALE;
FETUS MONITORING;
FEVER;
FOLLOW UP;
HIGH RISK PREGNANCY;
HUMAN;
HYPOCOMPLEMENTEMIA;
KIDNEY BIOPSY;
LEUKOPENIA;
LOW DRUG DOSE;
LUPUS ERYTHEMATOSUS NEPHRITIS;
POLYARTICULAR ARTHRALGIA;
PREECLAMPSIA;
PREGNANCY OUTCOME;
PREGNANT WOMAN;
PREMATURE LABOR;
PRIORITY JOURNAL;
PROTEINURIA;
REMISSION;
SERUM SICKNESS;
SYSTEMIC LUPUS ERYTHEMATOSUS;
THROMBOCYTOPENIA;
TREATMENT DURATION;
TREATMENT RESPONSE;
INCIDENCE;
LUPUS ERYTHEMATOSUS, SYSTEMIC;
NEWBORN;
PREGNANCY;
PREGNANCY COMPLICATIONS;
TREATMENT OUTCOME;
ADULT;
ANTIBODIES, MONOCLONAL, HUMANIZED;
EBSTEIN ANOMALY;
FEMALE;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
INCIDENCE;
INFANT, NEWBORN;
LUPUS ERYTHEMATOSUS, SYSTEMIC;
PREGNANCY;
PREGNANCY COMPLICATIONS;
PREGNANCY OUTCOME;
TREATMENT OUTCOME;
|
EID: 84930680545
PISSN: 00490172
EISSN: 1532866X
Source Type: Journal
DOI: 10.1016/j.semarthrit.2014.05.006 Document Type: Article |
Times cited : (42)
|
References (14)
|